These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 870000)

  • 21. Regulation of plasma factor XIII binding to fibrin in vitro.
    Greenberg CS; Dobson JV; Miraglia CC
    Blood; 1985 Nov; 66(5):1028-34. PubMed ID: 2413926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen Houston: a dysfibrinogen exhibiting defective fibrin monomer aggregation and alpha-chain cross-linkages.
    Weinger RS; Rudy C; Moake JL; Conlon CL; Cimo PL
    Am J Hematol; 1980; 9(3):237-48. PubMed ID: 6165239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subunits and susceptibility of fibrins formed from bovine fibrinogen by arvin, reptilase, thrombin and staphylothrombin.
    Zajdel M; Wegrzynowicz Z; Sawecka J; Kopeć M
    Thromb Res; 1975 Apr; 6(4):337-44. PubMed ID: 1169826
    [No Abstract]   [Full Text] [Related]  

  • 24. Simulating fibrin clotting time.
    Marx G
    Med Biol Eng Comput; 2006 Mar; 44(1-2):79-85. PubMed ID: 16929924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function.
    Riedelová-Reicheltová Z; Kotlín R; Suttnar J; Geierová V; Riedel T; Májek P; Dyr JE
    Thromb Haemost; 2014 Jan; 111(1):79-87. PubMed ID: 24108601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A naturally occurring antibody that inhibits fibrin polymerization.
    Hoots WK; Carrell NA; Wagner RH; Cooper HA; McDonagh J
    N Engl J Med; 1981 Apr; 304(15):857-61. PubMed ID: 7207522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myeloma.
    Panzer S; Thaler E
    Haemostasis; 1993; 23(1):69-76. PubMed ID: 8477911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinogen and dysfibrinogenemia.
    Morse EE
    Ann Clin Lab Sci; 1980; 10(4):351-5. PubMed ID: 7447388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibody to plasma fibrinopeptide A in a patient with a severe acquired haemorrhagic syndrome.
    Gris JC; Schved JF; Branger B; Aguilar-Martinez P; Vécina F; Oulès R; Sarlat C; Fourcade J
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):519-29. PubMed ID: 1450318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.
    Gralnick HR; Givelber H; Abrams E
    N Engl J Med; 1978 Aug; 299(5):221-6. PubMed ID: 207986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen Chapel Hill: hypodysfibrinogenemia with a tertiary polymerization defect.
    McDonagh RP; Carrell NA; Roberts HR; Blatt PM; McDonagh J
    Am J Hematol; 1980; 9(1):23-38. PubMed ID: 7435499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of calcium and synthetic peptides on fibrin polymerization.
    Furlan M; Rupp C; Beck EA; Svendsen L
    Thromb Haemost; 1982 Apr; 47(2):118-21. PubMed ID: 7101230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrin aggregation before sol-gel transition.
    Wiltzius P; Dietler G; Känzig W; Hofmann V; Häberli A; Straub PW
    Biophys J; 1982 May; 38(2):123-32. PubMed ID: 7093417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogen Chapel Hill II: defective in reactions with thrombin, factor XIIIa and plasmin.
    Carrell N; McDonagh J
    Br J Haematol; 1982 Sep; 52(1):35-47. PubMed ID: 6126210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen Amsterdam, another hereditary abnormality of fibrinogen.
    Janssen CL; Vreeken J
    Br J Haematol; 1971 Mar; 20(3):287-98. PubMed ID: 4101579
    [No Abstract]   [Full Text] [Related]  

  • 38. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.
    Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):463-71. PubMed ID: 7841300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfibrinogenaemia associated with primary hepatoma.
    Verhaeghe R; van Damme B; Molla A; Vermylen J
    Scand J Haematol; 1972; 9(5):451-8. PubMed ID: 4342317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.